525
Participants
Start Date
July 31, 2013
Primary Completion Date
May 31, 2014
Study Completion Date
December 31, 2014
Test Vaccine
NmVac4-A/C/Y/W-135-DT™ conjugate is a vaccine in liquid form composed of purified polysaccharides (PS) conjugated to diphtheria toxoid. Single intramuscular 0.5 mL dose contains 4 µg each of Serogroup A, C, W-135, and Y PS conjugated to approximately 26 µg total diphtheria toxoid.
US Licensed Vaccine
Meningococcal (Groups A,C,Y,W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine 0.5 mL dose, intramuscular. Single dose contains 4 µg each Serogroup A, C, W-135 and Y conjugated to approximately 48 µg total diphtheria toxoid.
Mid Atlantic Urology Associates LLC, Greenbelt
Chesapeake Research Group, Pasadena
IRC Clinics, Towson
Lead Sponsor
JN-International Medical Corporation
INDUSTRY